Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 44,900 shares at $15.96 ($717K) on 2020-02-06, disclosed to the SEC on 2020-02-10.
Open-market purchase of $717k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |